TNON
Tenon Medical, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$3.72
−1.33%Year over year
Reported trailing growth
- Revenue
- +80.9%
- EBITDA
- -2.0%
- EBIT
- -0.0%
- EPS
- +14.4%
- Free cash flow
- -19.8%
- Operating cash flow
- -19.9%
Forward estimates
Based on analyst estimates
- Revenue
- +21.0%
- EBITDA
- +83.1%
- EPS
- +74.2%
Three-year CAGR
- Revenue
- +78.7%
- EBITDA
- +7.4%
- EBIT
- +7.1%
- Net income
- +8.2%
- EPS
- +84.9%
- Free cash flow
- -9.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026